BNET Industries
Invitrogen Corp. is in the Pharma Industry
Latest News and Analysis
Invitrogen Wins Six Life Science Industry Awards
CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced it was the winner in six categories at the annual Life Science Industry Awards.
Invitrogen to Present at the UBS 2007 Global Life Science Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today that Greg Lucier, Chairman and Chief Executive Officer, will present at the UBS 2007 Global Life Science Conference being held at the Grand Hyatt, Park Avenue at Grand Central Terminal...
Invitrogen and FAST Create Premiere Life Science Search Capability
Invitrogen Website Enables Scientists to Solve a Fundamental Search Need by Providing Rich Scientific Data
Invitrogen Garners Six Life Science Industry Awards
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced it was recognized by the life sciences industry at The Scientists' annual Life Science Industry Awards, winning in six categories.
Invitrogen to Present at 2006 UBS Global Life Science Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced it will present at the 2006 UBS Global Life Science Conference on Tuesday, September 26, 2006 at 3:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City. To hear a live webcast of the presentation, visit the investor relations page...
Invitrogen Unveils New Innovations at American Association for Cancer Research Conference, Recognized by Peers at Life Science Industry Awards
WASHINGTON -- Industry Changing GIBCOR Functional Labels for Cell Culture Products and OmniaTM Kinase Assays That Measure Kinase Activity in Real Time Highlighted
Invitrogen and Wiley Partner to Offer Selected Current Protocols™ Online; Collaboration Provides Free Access to the Best Lab Methods Available Through New iProtocol™ Website
SAN FRANCISCO -- Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today announced the introduction of iProtocolTM, its latest technology and eScience contribution to the life sciences. Through a partnership with the global...
Invitrogen Launches Vector NTI® Advance™ 10; Release Includes Vector NTI® Open Access Policy and Vector NTI® User Community to Drive Life Science Standardization
CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today announced the release of its latest technology and eScience contribution to the life sciences, Vector NTI AdvanceTM 10. Centering on its...
Invitrogen to Present at UBS Global Life Sciences Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN), announced today that Gregory T. Lucier, Invitrogen's Chairman and CEO, will present at the UBS Global Life Sciences Conference in New York City, New York today, September 27 at 11:00 a.m. Eastern Time. Mr. Lucier's presentation will be webcast and available for viewing live...
Invitrogen To Present at the UBS Global Life Sciences Conference
CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) announced that Gregory T. Lucier, Chairman and Chief Executive Officer, will be speaking at the UBS Global Life Sciences Conference on Monday, September 27, 2004 at 8:30 a.m. ET. The conference is being held at The Grand Hyatt in New York, N.Y.
Additional Resources
Invitrogen, BayBio Sign Partnership Agreement
CARLSBAD, Calif. & SOUTH SAN FRANCISCO, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today its partnership with BayBio, a leading voice for the life sciences industry in Northern California. "BayBio is a vital voice for California's life...
Invitrogen and Applied Biosystems Announce European Commission Merger Clearance
Closing Date of Merger Scheduled for November 21, 2008; Deadline for Merger Consideration Elections to be Close of Business on November 19, 2008 CARLSBAD, Calif. & NORWALK, Conn. -- Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that they have received clearance from the European Commission...
Invitrogen Launches Microarray to Study Non-Coding RNA
Agilent Technologies to Manufacture Unique Array for Invitrogen CARLSBAD, Calif. & SANTA CLARA, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the first high-density microarray for the profiling of non-coding RNAs. The NCode[TM] Human...
Invitrogen Provides Update on Merger with Applied Biosystems
Three Applied Biosystems Board Members Named to New Board New Name Chosen for Combined Company CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) today announced progress against its integration plans regarding its pending merger with Applied Biosystems. The company announced that three members of the Applied...
Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: IVGN, DENN, POT, NOK, CP, MF
DALLAS, Oct. 30 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's Trade Alerts include: Invitrogen Corp. , Denny's Corp. , Potash Corp. of Saskatchewan...
Applied Biosystems Stockholders Approve Merger with Invitrogen
NORWALK, Conn. -- Applied Biosystems Inc. (NYSE:ABI) today announced that its stockholders have voted to approve the company's proposed merger with Invitrogen Corporation (NASDAQ:IVGN) at a special meeting of stockholders held today. "We are pleased with the overwhelming support of this transaction by our stockholders," said Tony L....
Invitrogen Shareholders Approve Merger with Applied Biosystems
Company Provides Update on Merger CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ: IVGN) today announced that its shareholders have voted to approve the company's proposed merger with Applied Biosystems Inc. (NYSE: ABI) at a special meeting of shareholders held today. "We are pleased with the outcome of...
Opportunities for Life Science Suppliers Plentiful in Rapidly Growing miRNA Research Markets
MicroRNA miRNA Segment Leaders Invitrogen and Applied Biosystems Face Many Niche Competitors - Revealed in New miRNA Market Research Report from Percepta Associates CARLSBAD, Calif. -- Today Percepta Associates Inc. announced the release of MicroRNA Analysis in North America: A research market report for life science tool providers....
Invitrogen Announces Third Quarter 2008 Financial Results
Third quarter revenue of $362 million, 15 percent increase Third quarter GAAP EPS of $0.26 and non-GAAP EPS $0.69 Free cash flow $61 million for the quarter CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced results for its third quarter ended September 30, 2008....
Applied Biosystems Adjourns Special Meeting of Stockholders Until October 28, 2008; Votes, Proxies and Merger Consideration Elections Already Submitted Will Remain Valid
Deadline for Cash, Stock, and Mixed Consideration Elections Expected to Be in November 2008 NORWALK, Conn. -- Consistent with its press release issued last week, Applied Biosystems Inc. (NYSE:ABI) adjourned Thursday's special meeting of stockholders relating to the pending merger with Invitrogen Corporation until 9:00 a.m. Eastern time...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View Related Content by Tag Close
Industry Transcripts by Seeking Alpha
-
Salix Pharmaceuticals, Ltd. Q3 2008 Earnings Call Transcript
on Nov 21, 2008about SLXP
-
Emergent BioSolutions Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about EBS
-
Amicus Therapeutics, Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about FOLD
-
Heska Corporation Q3 2008 Earnings Call Transcript
on Nov 20, 2008about HSKA
-
Mannatech Inc. Q3 2008 Earnings Call Transcript
on Nov 20, 2008about MTEX
Invitrogen Corp. Company Info
NAICS Code
Biological Product (except Diagnostic) Manufacturing: 325414
